Trials / Not Yet Recruiting
Not Yet RecruitingNCT07330310
A Phase 3 Trial of JKN2401 Injection in COPD
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous JKN2401 Injection in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 888 (estimated)
- Sponsor
- Joincare Pharmaceutical Group Industry Co., Ltd · Industry
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous JKN2401 Injection in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | JKN2401 Injection | JKN2401 subcutaneous injection, Q4W |
| OTHER | Placebo | Placebo subcutaneous injection,Q4W |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2027-09-01
- Completion
- 2027-11-01
- First posted
- 2026-01-09
- Last updated
- 2026-01-14
Source: ClinicalTrials.gov record NCT07330310. Inclusion in this directory is not an endorsement.